Gufic Biosciences Ltd (BOM:509079)
₹ 452.15 -3.1 (-0.68%) Market Cap: 45.34 Bil Enterprise Value: 48.66 Bil PE Ratio: 52.03 PB Ratio: 8.51 GF Score: 92/100

Q1 2023 Gufic Biosciences Ltd Earnings Call Transcript

Aug 12, 2022 / 11:00AM GMT
Release Date Price: ₹200.75 (-0.67%)
Operator

Ladies and gentlemen, good day, and welcome to the Q1 FY2022-23 earnings conference call of Gufic Biosciences Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Ms. Ami Shah, Company Secretary. Thank you, and over to you, ma'am.

Ami Shah
Gufic Biosciences Limited - Company Secretary, Compliance Officer

Thank you so much, Peter. Good evening, and a warm welcome to Gufic Biosciences Limited earnings conference call for first quarter of FY22-23. I have with me Mr. Pranav Choksi, Chief Executive Officer and Whole time Director; Mr. Devkinandan Roonghta, Chief Financial Officer; and Mr. Avik Das from Investor Relations team, to give the highlights of the business performance of the company, and to clarify all the queries of the investors during the call.

After the opening remarks from the management, operator will open the call for Q&A session. But before we proceed with the call, please note some of the statements made in today's discussion, may be forward-looking and are based on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot